These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20414709)

  • 21. [Reevaluation of the time course of the effect of propofol described with the Schnider pharmacokinetic model].
    Sepúlveda PO; Mora X
    Rev Esp Anestesiol Reanim; 2012 Dec; 59(10):542-8. PubMed ID: 23040653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refining Target-Controlled Infusion: An Assessment of Pharmacodynamic Target-Controlled Infusion of Propofol and Remifentanil Using a Response Surface Model of Their Combined Effects on Bispectral Index.
    Short TG; Hannam JA; Laurent S; Campbell D; Misur M; Merry AF; Tam YH
    Anesth Analg; 2016 Jan; 122(1):90-7. PubMed ID: 26683103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive ability of propofol effect-site concentrations during fast and slow infusion rates.
    Sepúlveda PO; Cortínez LI; Recart A; Muñoz HR
    Acta Anaesthesiol Scand; 2010 Apr; 54(4):447-52. PubMed ID: 20003124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of propofol: a multicenter study.
    Schüttler J; Ihmsen H
    Anesthesiology; 2000 Mar; 92(3):727-38. PubMed ID: 10719952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of the time course of the clinical effect of propofol compared with the time course of the predicted effect-site concentration: Performance of three pharmacokinetic-dynamic models.
    Coppens M; Van Limmen JG; Schnider T; Wyler B; Bonte S; Dewaele F; Struys MM; Vereecke HE
    Br J Anaesth; 2010 Apr; 104(4):452-8. PubMed ID: 20190259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.
    Calvo R; Telletxea S; Leal N; Aguilera L; Suarez E; De La Fuente L; Martin-Suarez A; Lukas JC
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1038-48. PubMed ID: 15315624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of Different Propofol Pharmacokinetics under Short and Prolonged Infusion Times in Rabbits.
    Campos S; Monteiro J; Valenzuela B; Gonçalinho H; de Pinho PG; Fresco P; Félix L; Antunes L
    Basic Clin Pharmacol Toxicol; 2016 Jun; 118(6):421-31. PubMed ID: 26551921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs.
    Lee SH; Ghim JL; Song MH; Choi HG; Choi BM; Lee HM; Lee EK; Roh YJ; Noh GJ
    Br J Pharmacol; 2009 Dec; 158(8):1982-95. PubMed ID: 19925493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propofol pharmacokinetic and pharmacodynamic profile and its electroencephalographic interaction with remifentanil in children.
    Fuentes R; Cortínez LI; Contreras V; Ibacache M; Anderson BJ
    Paediatr Anaesth; 2018 Dec; 28(12):1078-1086. PubMed ID: 30307663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the hemodynamic response to induction and intubation during a target-controlled infusion of propofol with 2 different pharmacokinetic models. A prospective ramdomized trial.
    Ramos Luengo A; Asensio Merino F; Castilla MS; Alonso Rodriguez E
    Rev Esp Anestesiol Reanim; 2015 Nov; 62(9):487-94. PubMed ID: 25600619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of cardiac output on propofol and fentanyl pharmacokinetics and pharmacodynamics in patients undergoing abdominal aortic surgery.
    Bienert A; Sobczyński P; Młodawska K; Hartmann-Sobczyńska R; Grześkowiak E; Wiczling P
    J Pharmacokinet Pharmacodyn; 2020 Dec; 47(6):583-596. PubMed ID: 32840723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of effective anesthesia induction doses using a wide range of infusion rates with undiluted and diluted propofol.
    Kazama T; Ikeda K; Morita K; Kikura M; Ikeda T; Kurita T; Sato S
    Anesthesiology; 2000 Apr; 92(4):1017-28. PubMed ID: 10754621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morbid Obesity Alters Both Pharmacokinetics and Pharmacodynamics of Propofol: Dosing Recommendation for Anesthesia Induction.
    Dong D; Peng X; Liu J; Qian H; Li J; Wu B
    Drug Metab Dispos; 2016 Oct; 44(10):1579-83. PubMed ID: 27481855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of time of day on propofol pharmacokinetics and pharmacodynamics in rabbits.
    Bienert A; Płotek W; Zawidzka I; Ratajczak N; Szczesny D; Wiczling P; Kokot ZJ; Matysiak J; Grześkowiak E
    Chronobiol Int; 2011 May; 28(4):318-29. PubMed ID: 21539423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data.
    Masui K; Upton RN; Doufas AG; Coetzee JF; Kazama T; Mortier EP; Struys MM
    Anesth Analg; 2010 Aug; 111(2):368-79. PubMed ID: 19861357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison between bispectral index analysis and auditory-evoked potentials for monitoring the time to peak effect to calculate the plasma effect site equilibration rate constant of propofol.
    Zhang MZ; Yu Q; Huang YL; Wang SJ; Wang XR
    Eur J Anaesthesiol; 2007 Oct; 24(10):876-81. PubMed ID: 17583594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do epoch lengths of hypnotic depth indicators affect estimated of blood-brain equilibration rate constants of propofol?
    Kim KM; Park S; Kang BJ; Choi BM; Noh GJ; Bang JY
    J Pharmacokinet Pharmacodyn; 2021 Apr; 48(2):305-317. PubMed ID: 33415524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient state index vs bispectral index as measures of the electroencephalographic effects of propofol.
    Soehle M; Kuech M; Grube M; Wirz S; Kreuer S; Hoeft A; Bruhn J; Ellerkmann RK
    Br J Anaesth; 2010 Aug; 105(2):172-8. PubMed ID: 20587537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacodynamics of two different propofol formulations].
    Ihmsen H; Jeleazcov C; Schüttler J; Schwilden H; Bremer F
    Anaesthesist; 2006 Jun; 55(6):635-42. PubMed ID: 16479409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis.
    Johnson KB; Egan TD; Kern SE; McJames SW; Cluff ML; Pace NL
    Anesthesiology; 2004 Sep; 101(3):647-59. PubMed ID: 15329589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.